LP-106

N/A

Report date: 2022/09/05 09:38:10

Base Information

Drug NameLP-106
Drug Alias NameLP-106
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXiamen Lp Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXiamen Lp Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A